Methylprednisolone Completed Phase 3 Trials for Degenerative Joint Disease

IndicationsStatusPurposePhase
CompletedNot Available3
clinicaltrials.gov IdentifierTitleDrugs
NCT02319343Effect of Methylprednisolone on Quadriceps Muscle Function in Patients Undergoing Total Knee-arthroplasty
NCT02332603Effect of Methylprednisolone on Glucose Homeostasis in Patients Undergoing Total Hip- and Knee-arthroplasty
NCT02332616Effect of Methylprednisolone on Complement Activation in Patients Undergoing Total Knee-arthroplasty
NCT02332629Effect of Methylprednisolone on Endothelial Function in Patients Undergoing Total Knee-arthroplasty